Berikutnya

Putar otomatis

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 Tampilan • 07/14/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis